Novacyt (LSE:NCYT)
Novacyt is an international diagnostics group with a portfolio of cancer and infectious disease products and services.
About
Last updated 04-06-2020, 05:06:11pm BSTRelated Articles
-
The Novacyt share price has 20-bagged in 2020. Is there still time to buy?
The Novacyt share price is flying as sales of Covid-19 tests soar. Alan Oscroft asks if the share price represents good long-term value. Read More »
-
The Novacyt share price has risen 2,500% this year! Is it worth adding to your ISA?
The Novacyt share price is up! The biotech company is making Covid-19 testing kits for the UK government. But is it worth investing your... Read More »
-
Novacyt share price surged 2,650% year-to-date! Can this wild ride continue?
The Novacyt share price is experiencing volatility as it commits to increasing coronavirus test orders. Can it meet market expectations? Read More »
-
Novacyt exploded higher, and I’m finding other strong-performing shares too
One thing I’m sure about more than anything right now. Stock-picking is king. And I’m finding some great shares. Here’s where. Read More »
-
Can coronavirus test-maker Novacyt still make you rich?
Coronavirus test-producer Novacyt (LON:NCYT) has likely made some savvy small-cap investors very wealthy. Could it still make money for new holders? Read More »
-
Coronavirus test maker Novacyt is up 2,750%! Here’s what I’d do now
Coronavirus testing company Novacyt has made early investors rich. With antibody testing on the way, Tom Rodgers looks at the options now. Read More »
-
Coronavirus test maker Novacyt soars 33% again. Here’s what I’d do now
UK AIM-listed coronavirus test maker Novacyt says it has scored two major new deals worth millions in revenue and shares have soared again. Is... Read More »
-
Coronavirus test maker Novacyt is up 900%. Here’s what I’d do now
Coronavirus is front page news across the globe. AIM-listed UK biotech firm Novacyt has a test for the virus. Is it a storming buy... Read More »